Related Experiment Video
Updated: Apr 19, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review
Eron Yones1,2, Julian Gunn3,2, Javaid Iqbal3,2
1School of Clinical Medicine and Population Health, The University of Sheffield, Sheffield, UK eron.yones2@nhs.net.
Insights
Assessing coronary artery disease (CAD) in severe aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI) is challenging. This review summarizes current data on functional CAD assessment in this population to guide optimal treatment strategies.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Many patients with severe aortic stenosis (AS) also have coronary artery disease (CAD).
- Optimal management strategies for concomitant severe AS and CAD, particularly during transcatheter aortic valve implantation (TAVI), remain debated.
- Current methods for assessing myocardial ischemia, like fractional flow reserve (FFR), are not validated in severe AS.
Purpose of the Study:
- To review current data on functional coronary artery disease (CAD) assessment in patients with severe aortic stenosis (AS).
- To highlight best practices for managing CAD in patients undergoing transcatheter aortic valve implantation (TAVI).
Main Methods:
- Review of existing prospective and observational studies on coronary physiology assessment in severe AS.
- Analysis of data from studies evaluating hyperemic and resting indices before and after TAVI.
- Examination of the limited randomized trial data on FFR-guided revascularization in TAVI patients.
Main Results:
- Limited evidence exists for routine FFR use in guiding revascularization during TAVI.
- Observational studies show changes in coronary indices in severe AS patients before and after TAVI.
- There is a need for better understanding and interpretation of coronary physiology in this specific patient group.
Conclusions:
- Functional assessment of CAD in severe AS patients undergoing TAVI requires further investigation.
- Current guidelines for ischemia assessment may not directly apply to patients with severe AS.
- Optimizing treatment pathways necessitates a clearer understanding of coronary physiology in this complex population.
Abstract:
A significant proportion of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) have concomitant coronary artery disease (CAD). The best way to treat these patients is contentious. Conventional assessments of ischaemia such as fractional flow reserve (FFR) and instantaneous wave-free ratio are not validated in the context of severe AS despite having a Class I European Society of Cardiology indication in patients with isolated coronary disease. A better understanding of how we assess and interpret coronary physiology in these patients is required to optimise treatment pathways. Only one prospective, randomised trial has investigated the routine use of FFR to guide revascularisation in patients undergoing TAVI and several observational cohort studies have measured changes in hyperaemic and resting indices in patients with severe AS as well as before and after TAVI. The purpose of this review article is to provide a summary of the current data regarding the functional assessment of CAD in patients with severe AS and highlight the current best practice in this evolving area.
Related Concept Videos
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies

